Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neutrophil function following therapy for APL

S R Frankel

    Leukemia
    |September 1, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2008
    Same author

    Extended rituximab therapy in Waldenström's macroglobulinemia.

    Annals of oncology : official journal of the European Society for Medical Oncology·2004
    Same author

    A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors.

    Annals of oncology : official journal of the European Society for Medical Oncology·2004
    Same author

    G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myeloma.

    Leukemia·2004
    Same author

    Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy.

    Bone marrow transplantation·2002
    Same author

    United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same journal

    Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms.

    Leukemia·2026
    Same journal

    Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

    Leukemia·2026
    Same journal

    Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

    Leukemia·2026
    Same journal

    Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.

    Leukemia·2026
    Same journal

    Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

    Leukemia·2026
    Same journal

    Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

    Leukemia·2026
    See all related articles